Breakthrough pancreatic cancer treatment could double survival time

NBC News Logo Meet the Press Politics U.S. News WorldLocalNew YorkLos AngelesChicagoDallas-Fort WorthPhiladelphiaWashington, D.C.BostonBay AreaSouth FloridaSan DiegoConnecticut Sports Shopping Tipline Business Culture Science HealthSubscribe Subscriber HubSavedNewslettersProfileSubscriptionPreferencesSearchSearchSectionsU.S. NewsPoliticsWorldBusinessSportsInvestigationsCulture & TrendsHealthScienceTechWeatherVIDEOPhotosNBC SelectNBC Asian AmericaNBC BLKNBC LatinoNBC OUTLocalNew YorkLos AngelesChicagoDallas-Fort WorthPhiladelphiaWashington, D.C.BostonBay AreaSouth FloridaSan DiegoConnecticuttvTodayNightly NewsMeet the PressDatelineFeaturedNBC News NowNightly FilmsStay TunedSpecial FeaturesNewslettersPodcastsListen NowMore From NBCNBC.COMNBCU AcademyPeacockNEXT STEPS FOR VETSNBC News Site MapHelpFollow NBC News news Alerts There are no new alerts at this time SearchSearchFacebookTwitterEmailSMSBlue SkyWhatsappPrintRedditFlipboardPinterestLinkedinLatest StoriesMeet the PressPoliticsU.S. NewsWorldSportsShoppingTiplineBusinessCultureScienceHealthBreakthrough pancreatic cancer treatment could double survival timeMay 31, 202602:32Good News: School’s challenge goes viral to support boy battling cancer01:50Security scares prompt diversions on two United flights01:28U.S. and Iran dig in as talks to end war stall01:39Sky-high cost for NBA Finals tickets01:25Urgent search for suspect in deputy’s killing01:04Now PlayingBreakthrough pancreatic cancer treatment could double survival time02:32UP NEXTFrance detains hundreds after violent clashes after soccer win01:07Maine Democratic Senate candidate under scrutiny over explicit texts02:10Curfew in place to crack down on clashes outside immigration facility02:01Inside China's push for global dominance: Evs, robotics, AI, pandas22:54Trump to hold rally at ‘Great America State Fair’ after artists back out01:27Good News: First-generation college graduates thank their families02:57Top W.H.O. official in Ebola epicenter as deadly outbreak spreads01:44A.I. lobbyists in statehouses across the U.S.03:36Dueling protests face off at New Jersey ICE detention center over detainee conditions01:49Mysterious loud boom rattles New England region01:34Four more men rescued after more than a week trapped in a flooded cave in Laos02:08Great Americans: A conversation with Ruby Bridges04:33Several artists back out of celebration for America’s 250th birthday01:43Trump to make ‘final determination’ on nuclear deal with Iranian regime00:57Nightly NewsBreakthrough pancreatic cancer treatment could double survival time02:32CopiedA new study on a groundbreaking pancreatic cancer drug finds that it has the potential to double survival rates for more than 90 percent of patients. Researchers are now exploring whether the drug, called daraxonrasib, could also be effective in lung, ovarian, and colorectal cancers. NBC News’ Erika Edwards reports.May 31, 2026 onGood News: School’s challenge goes viral to support boy battling cancer01:50Security scares prompt diversions on two United flights01:28U.S. and Iran dig in as talks to end war stall01:39Sky-high cost for NBA Finals tickets01:25Urgent search for suspect in deputy’s killing01:04Now PlayingBreakthrough pancreatic cancer treatment could double survival time02:32Get more newsLiveonBest of NBC News Nightly NewsGood News: School’s challenge goes viral to support boy battling cancerNightly NewsSecurity scares prompt diversions on two United flightsNightly NewsU.S. and Iran dig in as talks to end war stallNightly NewsSky-high cost for NBA Finals ticketsNightly NewsUrgent search for suspect in deputy’s killingNightly NewsBreakthrough pancreatic cancer treatment could double survival timePlay AllAboutContactHelpCareersAd ChoicesPrivacy PolicyYour Privacy ChoicesCA NoticeTerms of ServiceNBC News Subscription Terms of ServiceNBC News SitemapClosed CaptioningSubscribeAdvertiseNBC Select© 2026 NBCUniversal Media, LLC